UK:CO:PRNEWSWIRE
BerGenBio ASA
- Privately Held
locale
United Kingdom
market
PRIVATEindustry
Bio-pharmaceuticalwebsite
prnewswire.co.ukcrunchbase
sqream-technologies/linkedin
pr-newswire-emea-and-indiafounding date
Jan 01, 1954
BerGenBio ASA is a clinical-stage bio-pharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs. Their lead compound, bemcentinib, is a highly selective inhibitor of the receptor tyrosine kinase AXL, which is being developed for 1L STK11 mutated Non-Small Cell Lung Cancer (NSCLC) and severe respiratory infections. The company's focu...Show More